Discontinued — last reported Q4 '22
Elevance Health IngenioRx Segment — Restructuring Reserve remained flat by 0.0% to $1.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.00M to $1.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests management is planning significant operational changes or downsizing, while a decrease indicates the completion of restructuring activities or a reduction in planned reorganization scope.
This represents the accrued liability set aside to cover costs associated with reorganizing or streamlining the operatio...
Similar to restructuring accruals found in other healthcare services or PBM segments, often compared against total segment operating expenses to gauge the scale of transformation.
elv_segment_ingeniorx_segment_restructuring_reserve| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% |